University of California San Francisco
Give to UCSFLong COVID symptoms can persist for a year after initial infection, or re-emerge months later after disappearing.
An experimental blood test that reflects injury to nerve cells from multiple sclerosis (MS) was found to work for children with MS and other neurological conditions, even when they are symptom-free.
Taking daily medication can be a challenge for many, leading to increased viral load over time. Injectable therapies remove that challenge.
A common mutation can help people infected with the COVID-19 virus avoid developing any symptoms.
Deaths among older adults with dementia fell starkly in nursing homes and long-term care centers after COVID-19 vaccinations became available, but remained high for those living at home.
A new study shows that newborn screening for SCID is the only factor that actually boosts survival rates.
UCSF infectious disease specialist Michael Peluso, MD, who co-leads one of the world’s oldest studies of long COVID, discusses the condition’s mysteries.
In a breakthrough, “HT” became the first person in the world to receive gene-corrected stem cells for Artemis-SCID.